Cetirizine HCL tablets recalled for manufacturing process deviations
Glenmark Pharmaceuticals is voluntarily recalling Cetirizine HCL 10mg tablets distributed nationwide. The recall was initiated due to Current Good Manufacturing Practice deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a voluntary precautionary recall due to manufacturing process deviations. Per the severity rubric, voluntary precautionary recalls are classified as Moderate.
Plain-English summary
Glenmark Pharmaceuticals Inc. is recalling Cetirizine HCL 10mg tablets in 365-count packs distributed nationwide through retailers including Amazon and Walmart, with NDC# 72657-129-35.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing. This is a voluntary recall initiated by the manufacturer.
Affected lot numbers include 17231980, 17232044, 17241436, 17241437, 17241455, 17241456, 17241457, 17241892, and 17241893, with expiration dates ranging from August 2025 to October 2026. Consumers should check their product packaging to determine if their medication is affected.
If you have this product, do not use it and return it to the place of purchase. Consult your healthcare provider if you have questions about your medication.
The recalled product
- Product
- CETIRIZINE HCL (CETIRIZINE)
- Brand
- CETIRIZINE HCL
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot # 17231980
- ep.. date Aug-25 Amazon 17232044
- ep.. date Aug-25 Walmart 17241436
- ep.. date Jul-26 Amazon 17241437
- ep.. date Jul-26 Amazon 17241455
- ep.. date Jul-26 Amazon 17241456
- ep.. date Aug-26 Amazon 17241457
- ep.. date Aug-26 Amazon 17241892
- ep.. date Oct-26 Amazon 17241893
- ep.. date Oct-26 Amazon
UPCs (1)
- 0372657129350
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 39 recalled by Glenmark Pharmaceuticals Inc., USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 39 products in this recall →Related recalls
Same manufacturer · Glenmark Pharmaceuticals Inc., USA
See all →- ModerateAzelaic Acid Gel 15% Recalled Over Grainy, Gritty, or Sandy Texture
FDA (Drugs) · 2026-08-05
- ModerateAlyacen 7/7/7 birth control tablets failed total impurities specification
FDA (Drugs) · 2026-06-24
- ModerateOndansetron tablets recalled because blister packs are not fully sealed
FDA (Drugs) · 2026-01-07
- CriticalFrozen chopped methi recalled after testing positive for Salmonella
FDA (Drugs) · 2025-12-17
- ModerateBisoprolol and hydrochlorothiazide tablets recalled over traces of another drug
FDA (Drugs) · 2025-12-10
Same hazard · cgmp deviation
See all →- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Vancomycin Injection Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09